Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Siddoway

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|September 10, 1977
Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit associationT A Springer, J F Kaufman, L A Siddoway, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibersK A Thompson, D H Iansmith, L A Siddoway, et al.
American Heart Journal|October 1, 1983
Amiodarone dosing: a proposal based on its pharmacokineticsL A Siddoway, C B McAllister, G R Wilkinson, et al.
Journal of Cardiovascular Pharmacology|July 1, 1990
Pharmacokinetics of recombinant human superoxide dismutaseH S Silverman, L A Siddoway, Z Yavin, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1988
The automatic implantable cardioverter defibrillator: T wave sensing in the newest generationI Singer, R de Borde, E P Veltri, et al.
Circulation|April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequencesL A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology|May 1, 1986
Concentration-dependent pharmacologic properties of sotalolT Wang, R H Bergstrand, K A Thompson, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|September 10, 1977
Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit associationT A Springer, J F Kaufman, L A Siddoway, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibersK A Thompson, D H Iansmith, L A Siddoway, et al.
American Heart Journal|October 1, 1983
Amiodarone dosing: a proposal based on its pharmacokineticsL A Siddoway, C B McAllister, G R Wilkinson, et al.
Journal of Cardiovascular Pharmacology|July 1, 1990
Pharmacokinetics of recombinant human superoxide dismutaseH S Silverman, L A Siddoway, Z Yavin, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1988
The automatic implantable cardioverter defibrillator: T wave sensing in the newest generationI Singer, R de Borde, E P Veltri, et al.
Circulation|April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequencesL A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology|May 1, 1986
Concentration-dependent pharmacologic properties of sotalolT Wang, R H Bergstrand, K A Thompson, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
Pageof 3